Exact Mass: 546.1176
Exact Mass Matches: 546.1176
Found 254 metabolites which its exact mass value is equals to given mass value 546.1176
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ceftazidime
Ceftazidime is only found in individuals that have used or taken this drug. It is a semisynthetic, broad-spectrum antibacterial derived from cephaloridine and used especially for Pseudomonas and other gram-negative infections in debilitated patients. [PubChem]The bactericidal activity of ceftazidime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
dTDP-L-mycarose
A dTDP-sugar having beta-L-mycarose as the sugar component.
6'-O-Malonylwistin
6-O-Malonylwistin is found in pulses. 6-O-Malonylwistin is isolated from Medicago sativa (alfalfa). Isolated from Medicago sativa (alfalfa). Afrormosin 7-(6-malonylglucoside) is found in pulses.
Biochanin A 7-(6-methylmalonylglucoside)
Biochanin A 7-(6-methylmalonylglucoside) is found in herbs and spices. Biochanin A 7-(6-methylmalonylglucoside) is isolated from leaves of Trifolium pratense (red clover
alpha-D-Galactopyranuronosyl-(1->4)-alpha-D-galactopyranuronosyl-(1->4)-D-galacturonic acid
alpha-D-Galactopyranuronosyl-(1->4)-alpha-D-galactopyranuronosyl-(1->4)-D-galacturonic acid is isolated from enzymic hydrolysates (yeast or mould pectinases) of pectic acid. Also from partial acid hydrolysis of Medicago sativa (lucerne) pectin. Isolated from enzymic hydrolysates (yeast or mould pectinases) of pectic acidand is) also from partial acid hydrolysis of Medicago sativa (lucerne) pectin
Ceftazidime anhydrous
hypocrellin a
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents D003879 - Dermatologic Agents Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4]. Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4].
Telotristat
Hypocrellin
Hypocrellin is a natural product found in Parastagonospora nodorum with data available. Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4]. Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4].
Afrormosin 7-O-(6-malonylglucoside)
8)-epicatechin
6,7-Dihydro-6-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-7-hydroxy-8H-pyrano[3,2-g]fisetinidol
hypocrellin a
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents D003879 - Dermatologic Agents Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4]. Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4].
8,9-Dihydro-10-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-9-hydroxy-10H-pyrano[2,3-h]fisetinidol
Judaicin 7-O-(6-O-malonylglucoside)
4-(2,4-Dihydroxyphenyl)-2-(3,4-dihydroxyphenyl)-3,3,4,4-tetrahydro(2,6)-bis-2H-1-benzopyran3,3,7,8-tetraol
Scutellarein 4-methyl ether 7-(2,6-diacetylalloside)
Isorhamnetin 3-[6-(2-(E)-butenoyl)-glucoside]
8,9-Dihydro-10-(2,4-dihydroxyphenyl)-9-hydroxy-8-(4-hydroxyphenyl)-10H-pyrano[2,3-h]-ent-fisetinidol
6,7-Dihydro-6-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-7-hydroxy-8H-pyrano[3,2-g]-ent-epifisetnidol
8,9-Dihydro-10-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-9-hydroxy-10H-pyrano[2,3-h]-ent-epifisetinidol
Ustilaginoidin C
A binaphthopyran resulting from the formal oxidative coupling at position 9 of two molecules of 5,6,8-trihydroxy-2-(hydroxymethyl)-4H-naphtho[2,3-b]pyran-4-one.
5,2,6-trihydroxy-7-methoxyflavone-2-O-(2,6-di-O-acetyl-beta-D-glucopyranoside)
phomalevone A
A biaryl that is 5,5,10a,10a-tetrahydro-9H,9H-2,2-bixanthene-9,9-dione substituted by hydroxy groups at positions 1, 1, 5, 5, 8 and 8 and methyl groups at positions 3, 3, 10a and 10a. Isolated from the cultures of a Hawaiian isolate of the fungus Phoma species, it exhibits antibacterial activity.
Phomalevone B
A member of the class of biphenyls that is 6,6-dimethylbiphenyl-2,2,4,4-tetrol which has been substituted by 3,6-dihydroxy-2-methylbenzoyl groups at positions 3 and 3. Isolated from the cultures of a Hawaiian isolate of the fungus Phoma species, it exhibits antibacterial and antifungal activities.
physcion 8-O-beta-D-(6-methylmalonyl)-glucopyranoside|polyganin B
(E)-3,3?-(2-methylpropane-1,1-diyl)-bis(6-((E)-3,4-dihydroxystyryl)-4-hydroxy-2H-pyran-2-one)|phaeolschidin A
7-O-beta-D-glucopyranosyl-(1?6)-beta-D-glucopyranosyl-6,8-dimethoxy-7-hydroxycoumarin|nitensoside B
4-O-methylellagic acid 3-(2,3-di-O-acetyl)-alpha-L-rhamnoside|4-O-Methylellagic acid 3-(2,3-di-O-acetyl)-??-L-rhamnoside|4-O-methylellagic acid 3-(2,3-di-O-acetyl)-3-alpha-rhamnoside
5,2,6-trihydroxy-7-methoxyflavone-2-O-(3,6-di-O-acetyl-beta-D-glucopyranoside)
(11S,13R,14S,15S,16R)-2,2,11,13,15,16-hexachlorodocosane-1,14-diol
4xi,5xi-di(3,4-dihydroxy-(E)-cinnamoyl)-2,6xi-dihydroxyhept-2-en-1,7-dioic acid
6-(3,7-dihydro xychroman-2-yl)-4-(2,4-dihydroxyphenyl)-3,3,4,8-tetrahydro xyflavan
rhein-8-O-beta-D-[6-O-(3-methoxymalonyl)]glucopyranoside
Pectic acid
Ceftazidime
A cephalosporin bearing pyridinium-1-ylmethyl and {[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams CONFIDENCE standard compound; EAWAG_UCHEM_ID 3238
Bepotastine Besilate
C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Bepotastine besilate is a selective and orally active second-generation histamine H1 receptor antagonist, can suppress the expression of nerve growth factor (NGF). Bepotastine besilate has the potential for allergic rhinitis, allergic conjunctivitis and urticaria/pruritus research[1][2][3][4].
Isoflavone base + 1O, 2MeO, O-MalonylHex
Annotation level-3
Cys Met Met Tyr
Cys Met Tyr Met
Cys Tyr Met Met
Met Cys Met Tyr
Met Cys Tyr Met
Met Met Cys Tyr
Met Met Tyr Cys
Met Tyr Cys Met
Met Tyr Met Cys
Tyr Cys Met Met
Tyr Met Cys Met
Tyr Met Met Cys
Biochanin A 7-(6-methylmalonylglucoside)
6''-O-Malonylwistin
Trigalacturonic acid
1-[[(6R,7R)-7-[[(2E)-(2-Amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-pyridinium inner salt
[4-({4-(6-Methoxy-3-pyridinyl)-5-[4-(trifluoromethoxy)phenyl]-1,3 -thiazol-2-yl}methoxy)-2-methylphenoxy]acetic acid
β-D-Mannopyranuronic acid
Alginic acid is a natural polysaccharide, which has been widely concerned and applied due to its excellent water solubility, film formation, biodegradability and biocompatibility. Alginic acid induces oxidative stress-mediated hormone secretion disorder, apoptosis and autophagy in mouse granulosa cells and ovaries. Alginic acid has an inhibitory effect on histamine release. Anti-anaphylactic and anti-inflammatory properties[1][2][3]. Alginic acid is a natural polysaccharide, which has been widely concerned and applied due to its excellent water solubility, film formation, biodegradability and biocompatibility. Alginic acid induces oxidative stress-mediated hormone secretion disorder, apoptosis and autophagy in mouse granulosa cells and ovaries. Alginic acid has an inhibitory effect on histamine release. Anti-anaphylactic and anti-inflammatory properties[1][2][3].
CHAETOCHROMIN A
A biaryl that is 2,2,3,3-tetrahydro-4H,4H-9,9-bibenzo[g]chromene-4,4-dione substituted by hydroxy groups at positions 5, 5, 6, 6, 8 and 8 and methyl groups at positions 2, 2, 3 and 3 (the 2R,2S,3R,3S stereoisomer). It has been isolated from Chaetomium gracile.
Telotristat
A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AX - Various alimentary tract and metabolism products C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent C471 - Enzyme Inhibitor
(R)-6-Amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
Defactinib hydrochloride
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
alpha-D-GalpA-(1->4)-alpha-D-GalpA-(1->4)-alpha-D-GalpA
A trisaccharide in which three alpha-D-galactopyranuronic acid units are joined via (1->4)-linkages.
Chaetochromin B
A biaryl that is 2,2,3,3-tetrahydro-4H,4H-9,9-bibenzo[g]chromene-4,4-dione substituted by hydroxy groups at positions 5, 5, 6, 6, 8 and 8 and methyl groups at positions 2, 2, 3 and 3 (the 2R,2S,3R,3R stereoisomer). It has been isolated from Chaetomium gracile.
dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose(1-)
7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Rhythmy
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives
Afzelechin-(4alpha->8)-afzelechin
A biflavonoid consisting of two molecules of afzelechin joined by a (4alpha->8) linkage.
N-[3-(benzenesulfonyl)-1-cyclohexyl-2-pyrrolo[3,2-b]quinoxalinyl]benzenesulfonamide
(2R,2S,3R,3S)-5,5,6,6,8,8-hexahydroxy-2,2,3,3-tetramethyl-2,2,3,3-tetrahydro-4H,4H-9,9-bibenzo[g]chromene-4,4-dione
6-[3,5-Dihydroxy-2-(3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-6-yl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[5,7-Dihydroxy-2-(3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-6-yl)-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
1-{[(6R,7R)-2-carboxy-7-[(2Z)-2-[(1-carboxylato-1-methylethoxy)imino]-2-(2-imino-2,3-dihydro-1,3-thiazol-4-yl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium
4',5,6-trihydroxy-4-(4-hydroxyphenyl)-2-{[(2z)-3-[(2r,3s)-3-methyloxiran-2-yl]prop-2-enoyl]oxy}-[1,1'-biphenyl]-3-yl (2z)-3-[(2r,3s)-3-methyloxiran-2-yl]prop-2-enoate
3-oxo-3-{[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[3-(6-methoxy-2h-1,3-benzodioxol-5-yl)-2h-chromen-7-yl]oxy}oxan-2-yl]methoxy}propanoic acid
(2r,3s)-8-[(2r,3s,4s)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
(2r,3r)-8-[(2s,4r)-7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
4',5,6-trihydroxy-4-(4-hydroxyphenyl)-2-{[3-(3-methyloxiran-2-yl)prop-2-enoyl]oxy}-[1,1'-biphenyl]-3-yl 3-(3-methyloxiran-2-yl)prop-2-enoate
(2r,3s,4s)-2-(3,4-dihydroxyphenyl)-4-[(2r,3s)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3,4-dihydro-2h-1-benzopyran-3,7-diol
3-(acetyloxy)-2-{[5,7-dihydroxy-2-(4-methoxyphenyl)-4-oxochromen-3-yl]oxy}-5-hydroxy-6-(hydroxymethyl)oxan-4-yl acetate
4-[(5r,5''r)-5,5''-bis[(1s)-1-hydroxyethyl]-2'-(4-hydroxyphenyl)-5h,5''h-dispiro[furan-2,5'-[4,6,10,12]tetraoxatricyclo[7.3.0.0³,⁷]dodecane-11',2''-furan]-1',3'(7'),8'-trien-8'-yl]phenol
methyl (1s,4as,7r,7as)-4'-(4-hydroxybenzoyl)-5'-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4a,7a-dihydro-1h-spiro[cyclopenta[c]pyran-7,2'-furan]-4-carboxylate
(2s,3r)-5,6,8-trihydroxy-2,3-dimethyl-9-[(2r,3r)-5,6,8-trihydroxy-2,3-dimethyl-4-oxo-2h,3h-naphtho[2,3-b]pyran-9-yl]-2h,3h-naphtho[2,3-b]pyran-4-one
(2r,13s)-16-(2,6-dihydroxy-4-methylbenzoyl)-1,8,10,15,18-pentahydroxy-2,6,17-trimethyl-3-oxapentacyclo[11.6.1.0²,¹¹.0⁴,⁹.0¹⁴,¹⁹]icosa-4,6,8,10,14,16,18-heptaen-12-one
1,1',4',5,5',8'-hexahydroxy-3,7-dimethyl-1',2',3',4',5',6',7',8'-octahydro-[2,2'-bianthracene]-9,9',10,10'-tetrone
(5r,5''s,6''r)-5-[(1s)-1-hydroxyethyl]-2',8'-bis(4-hydroxyphenyl)-6''-methyl-5'',6''-dihydro-5h-dispiro[furan-2,5'-[4,6,10,12]tetraoxatricyclo[7.3.0.0³,⁷]dodecane-11',2''-pyran]-1',3'(7'),8'-trien-5''-ol
5-methyl-3,4,6-trioxo-11-oxa-2,5-diazatricyclo[7.5.0.0²,⁷]tetradeca-7,9,12-trien-14-yl 3-(5-formyl-2-methoxyphenoxy)-4-methoxybenzoate
[(2r,3s,4s,5r,6s)-6-{[2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4-oxochromen-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-2-methylbut-2-enoate
3-[(7-{[(2s,3r,4s,5s,6s)-3,4-dihydroxy-6-(hydroxymethyl)-5-methyloxan-2-yl]oxy}-5-hydroxy-3-(4-methoxyphenyl)-4-oxochromen-2-yl)oxy]-3-oxopropanoic acid
(13s,14r)-14-acetyl-7,13,19-trihydroxy-5,10,16,21-tetramethoxy-13-methylhexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3,5,7,10,15,18(23),19,21-nonaene-9,17-dione
[(2r,3r,4s,5r,6s)-4-(acetyloxy)-3,5-dihydroxy-6-[3-hydroxy-2-(5-hydroxy-7-methoxy-4-oxochromen-2-yl)phenoxy]oxan-2-yl]methyl acetate
(2s,3s,4s)-2-(4-hydroxyphenyl)-4-[(2r,3r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-8-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
(12s,13r)-12-acetyl-9,13,17-trihydroxy-5,10,16,21-tetramethoxy-13-methylhexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1(15),2(11),3(8),4(22),5,9,16,18(23),20-nonaene-7,19-dione
2,3,7-trihydroxy-9-methoxy-4-{2,3,7-trihydroxy-9-methoxy-6-oxobenzo[c]chromen-1-yl}benzo[c]chromen-6-one
(2r,3r)-2-(4-hydroxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
3',4',7-trihydroxyflavan(4→8)-3,3',4',5,7-pentahydroxyflavan; (2s,2'r,3's,4r)-form
{"Ingredient_id": "HBIN007318","Ingredient_name": "3',4',7-trihydroxyflavan(4\u21928)-3,3',4',5,7-pentahydroxyflavan; (2s,2'r,3's,4r)-form","Alias": "NA","Ingredient_formula": "C30H26O10","Ingredient_Smile": "NA","Ingredient_weight": "546.52","OB_score": "NA","CAS_id": "162753-74-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8302","PubChem_id": "NA","DrugBank_id": "NA"}
3',4',7-trihydroxyflavan(4→8)-3,3',4',5,7-pentahydroxyflavan; (2s,2'r,3's,4s)-form
{"Ingredient_id": "HBIN007319","Ingredient_name": "3',4',7-trihydroxyflavan(4\u21928)-3,3',4',5,7-pentahydroxyflavan; (2s,2'r,3's,4s)-form","Alias": "NA","Ingredient_formula": "C30H26O10","Ingredient_Smile": "NA","Ingredient_weight": "546.52","OB_score": "NA","CAS_id": "162869-46-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8301","PubChem_id": "NA","DrugBank_id": "NA"}
4'-o-methylellagicacid 3-(2'',3''-di-o-acetyl)-α-l-rhamnoside
{"Ingredient_id": "HBIN010778","Ingredient_name": "4'-o-methylellagicacid 3-(2'',3''-di-o-acetyl)-\u03b1-l-rhamnoside","Alias": "NA","Ingredient_formula": "C25H22O14","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14335","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
afzelechin-(4α→8)-afzelechin
{"Ingredient_id": "HBIN014789","Ingredient_name": "afzelechin-(4\u03b1\u21928)-afzelechin","Alias": "NA","Ingredient_formula": "C30H26O10","Ingredient_Smile": "C1C(C(OC2=C1C(=CC(=C2C3C(C(OC4=CC(=CC(=C34)O)O)C5=CC=C(C=C5)O)O)O)O)C6=CC=C(C=C6)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "678","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}